Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
21.04.2023
Sernova Reminds Shareholders to Vote FOR the Eight Management Director Nominees Using ONLY the WHITE Management Proxy
18.04.2023
Two Independent Proxy Advisory Firms, Including Glass Lewis & Co. LLC. Recommend Sernova’s Shareholders Vote FOR all Management Nominees on Management’s White Proxy
14.04.2023
Institutional Shareholder Services Inc. Recommends Senova's Shareholders Vote FOR all Management Nominees on Management's White Proxy
06.04.2023
Sernova Responds to Dissident Shareholders’ Misleading Statements and Provides Corporate Updates
17.11.2022
Sernova Announces First Two Patients Implanted with Cell Pouch™ in the Second Cohort of its US Phase 1/2 Clinical Trial for Type 1 Diabetes
03.11.2022
Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System™ for Type 1 Diabetes
22.09.2022
Sernova Announces Full Exercise of Share Purchase Warrants Expiring September 22, 2022
08.09.2022
Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium
07.09.2022
Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors
01.09.2022
Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share
First
Previous
1
2
3
4
5
6
7
Next
Last